Mast cells are known to play a pivotal role in allergic diseases. Cross-linking of the high-affinity receptor for IgE (Fc3RI) leads to degranulation and allergic inflammation; however, the regulatory mechanisms of IgE-dependent exocytosis remain unknown. We show here that IkB kinase (IKK) 2 in mast cells plays critical roles in IgE-mediated anaphylaxis in vivo, and IgE-mediated degranulation in vitro, in an NF-kB-independent manner. Upon Fc3RI stimulation, IKK2 phosphorylates SNAP-23, the target membrane soluble N-ethylmaleimide-sensitive fusion factor attachment protein receptor (SNARE), and ectopic expression of a phospho-mimetic mutant of SNAP-23 partially rescued the impaired IgE-mediated degranulation in IKK2-deficient mast cells. These results suggest that IKK2 phosphorylation of SNAP-23 leads to degranulation and anaphylactic reactions. While this reaction is NF-kB-independent, we additionally show that IKK2 also regulates late-phase allergic reactions promoted by the release of proinflammatory cytokines in an NF-kB-dependent manner. The findings suggest that IKK2 is a central player in allergic reactions.
INTRODUCTION
Mast cells are recognized as the major effector cells of the type I hypersensitivity reactions because of their high-affinity receptors for IgE (Fc3RI). They are known to play a pivotal role in allergic diseases (Galli et al., 2005a (Galli et al., , 2005b , such as atopic rhinitis, asthma, and atopic dermatitis. Engagement of Fc3RI by IgE, followed by the aggregation of multiple IgE-bearing Fc3RI molecules by polyvalent antigen, leads to degranulation, and release of histamine, LTC4, and other preformed chemical mediators. Additionally, multiple cytokine genes are transcribed and newly synthesized arachidonic acid metabolites are secreted, all of which trigger allergic inflammation (Galli et al., 2005a (Galli et al., , 2005b . It is well established that mast cells mediate the early phase of type I hypersensitivity reactions by releasing granule contents after Fc3RI crosslinking (Bischoff, 2007) . However, the precise regulatory mechanisms that lead to IgE-dependent exocytosis in mast cells remain unknown. Furthermore, allergic diseases do not consist only of early-phase reactions, but also of late-phase reactions that occur facultatively following early-phase reactions, and are thought to cause chronic inflammation. Mast cells induce the recruitment of neutrophils by releasing TNF-a and IL-8. In mouse models, mast cell-secreted TNF-a plays an important role in late-phase allergic reactions in an NF-kB-dependent manner (Klemm et al., 2006 ). The precise role of IkB kinase (IKK) 2 in mast cells in late-phase allergic reactions remains unknown.
Soluble N-ethylmaleimide-sensitive fusion factor attachment protein receptor (SNARE) proteins play a central regulatory role in exocytosis by promoting vesicle fusion with the plasma membrane (Jahn and Sudhof, 1999) . Degranulation requires the association of v-SNAREs and t-SNAREs to form a ternary SNARE complex that catalyzes membrane fusion. The SNARE complex brings the two membranes in apposition, a necessary step in overcoming the energy barrier required for membrane fusion. In mast cells, these include syntaxin 4 (Paumet et al., 2000) and SNAP-23 (Guo et al., 1998) as t-SNAREs, while VAMP-2 (Miesenbock et al., 1998) and VAMP-8 (Paumet et al., 2000) represent candidates for v-SNAREs. The syntaxin binding proteins Munc18b and Munc18c are also essential for exocytosis in mast cells (Martin-Verdeaux et al., 2003) . It has been shown that phosphorylation of SNAP-23 modulates exocytosis (Lin and Scheller, 2000; Marash and Gerst, 2001; Hepp et al., 2005) . Although protein kinase C can phosphorylate SNAP-23 in vitro, it has not been established as to which kinase phosphorylates SNAP-23 in vivo and regulates exocytosis in mast cells (Hepp et al., 2005) .
Transcription factors of the NF-kB family regulate hundreds of genes in the context of multiple important biological processes, such as apoptosis, proliferation, innate and adaptive immune responses, and inflammation (Hayden and Ghosh, 2004; Li and Verma, 2002) . The IKK complex coordinates the response to most of the external signals leading to the induction of NF-kBactivated gene transcription. The activity of the IKK complex resides in two catalytic subunits, IKK1 (also called IKK a) and IKK2 (also called IKK b), and two regulatory subunits, NEMO and ELKs (Hayden and Ghosh, 2004; Li and Verma, 2002; Scheidereit, 2006; Perkins, 2007) . Interestingly, IKK2 is the major cytokine-responsive IkB kinase and, thus, is a central component of the intracellular signaling pathway mediating NF-kB activation (Scheidereit, 2006; Perkins, 2007) . We report that IKK2 in mast cells plays a critical role in IgE-mediated anaphylaxis in vivo and IgE-mediated degranulation in vitro in an NF-kB-independent manner. IKK2 is recruited into the lipid raft fractions and phosphorylates SNAP-23 at Ser120 and Ser95 upon Fc3RI stimulation, leading to upregulation of IgE-mediated degranulation in mast cells. The late-phase allergic reactions initiated by release of proinflammatory cytokines is also regulated by IKK2 kinase, but requires NF-kB activity. We conclude that IKK2 kinase regulates both the early-and late-phase allergic reactions.
RESULTS

Severe Impairment of Anaphylactic Responses in the Absence of IKK2
To investigate the role of IKK2 on anaphylactic responses in vivo, we used mast cell knock-in mouse model (Galli et al., 2005a (Galli et al., , 2005b . FLMCs were generated from Days 11.5-12.5 embryonic liver of wild-type (WT) or IKK2-deficient (IKK2 À/À ) mice because of the lethality in the IKK2 À/À embryos at E14 (Li et al., 1999a ]; n = 10). Liver cells isolated from both genotypes proliferated and expanded normally when cultured in the presence of 100 ng/ml IL-3. After 4 weeks, more than 98% of cells were c-kit positive, and the number of mast cells (c-kit + IgE + cells) recovered per mouse was indistinguishable between these mice (see Figure S1A available online). We confirmed the lack of IKK2 expression of fetal liver-derived mast cells (FLMCs) from IKK2 À/À mice ( Figure S1B ). The expression levels of c-kit and Fc3RIa were also indistinguishable ( Figure S1C ). The WT and IKK2 À/À FLMC were morphologically indistinguishable by electron microscopy ( Figure S1D ). Especially, there was no significant difference in the number of granules ( Figure The number of granules in each mast cell was counted and the density of individual granules was measured and analyzed with Image J software (NIH, Bethesda, MD). Furthermore, most of WT and IKK2 À/À FLMCs were annexin-V-and 7-AAD-negative ( Figure S1E ). IgE-induced Ca 2+ flux was also normal in IKK2 À/À FLMCs ( Figure S2 ). These results indicate that IL-3-induced mast cell development in vitro is not dependent on IKK2 activity. Figure 1A ) and leakage of injected Evans blue dye (Figures 1B and 1C) . We also demonstrated similar experiments in the nonreconstituted W/W v mice and confirmed lack of anaphylactic reactions in these mice as previously described (Galli et al., 2005a , and our unpublished data). Since mast cell numbers in the ear skin were identical between WT FLMC-reconstituted mice and IKK2
À/À FLMC-reconstituted mice (WT [14.6 ± 4.4/mm] versus IKK2 À/À [15.6 ± 4.6/mm], n = 8), the diminished anaphylaxis in IKK2 À/À FLMC-reconstituted mice was most likely due to mast cell hyporeactivity to the antigen. We next examined passive systemic anaphylaxis (PSA) by measuring decrease of body temperature after antigen challenge. Figure 1D shows a decrease in PSA in the IKK2 À/À FLMC-reconstituted mice. These data imply a physiological role of IKK2 in mast cells is to induce appropriate mast cell degranulation. Figure 2C ). We next determined the amount of annexin-V specifically bound to mast cell granules exposed after stimulation with Fc3RI (Demo et al., 1999) . IKK2
À/À
FLMCs showed reduced annexin-V binding than WT FLMCs ( Figure 2D ). We also examined the effect of overexpression of IKK2 in the mast cells on Fc3RI-stimulated b-hexosaminidase release. We examined Fc3RIa expression and apoptosis (annexin-V binding) on RBL-2H3 cells stably expressing GFP or GFP-IKK2 and confirmed no significant difference between those cells (data not shown). RBL-2H3, a rat basophilic cell line stably expressing GFP-IKK2 ( Figure 2F ), resulted in the increase of Fc3RI-stimulated b-hexosaminidase release (mock [43.8% ± 4.0%] versus IKK2 [63.0% ± 4.8%]; n = 5; p < 0.01) ( Figure 2E ). In order to determine whether kinase activity of IKK2 is required for IKK2-mediated upregulation of Fc3RI-stimulated b-hexosaminidase release ( Figure 2E ), we examined the effect of overexpression of IKK2KM, a kinase-inactive mutant of IKK2 (Mercurio et al., 1997) , on Fc3RI-stimulated b-hexosaminidase release. Overexpression of IKK2KM ( Figure 2F ) did not enhance Fc3RI-stimulated b-hexosaminidase release (mock [43.8% ± 4.0%] versus IKK2KM [38.1% ± 3.9%]; n = 5) ( Figure 2E ). These results suggest that IKK2 modulates FLMCs were stimulated with (black columns) or without (white columns) A23187 (500 ng/ml). After 30 min, the percentage of specific b-hexosaminidase release was determined as described in the Experimental Procedures. Data are means ± SD from five independent experiments. *Significantly different from the mean value of control group (WT), *p < 0.01. IgE-induced b-hexosaminidase release was performed as described in Figure 2A .
Data are means ± SD from five independent experiments. *Significantly different from the mean value of control group (mock), *p < 0.01. NS, not significant.
(F) Western blots to assess expression of GFP, GFP-IKK2, or GFP-IKK2KM in zeocin-resistant RBL-2H3 cells ( Figure 2G ). Antitubulin blots were used as loading controls.
antigen-induced mast cell degranulation in a kinase activitydependent manner.
NF-kB Activation Is Not Essential for Mast Cell Degranulation
The seminal event in NF-kB activation is the phosphorylation of IkBs, which is mediated by IKK complex. We therefore examined the role of NF-kB activation in Fc3RI-induced degranulation. RBL-2H3 cells stably expressing GFP-tagged IkBa superrepressor (IkBaM) (Karin and Ben-Neriah, 2000) ( Figure 3C ) and HIV3x-kB luciferase/b-galactosidase plasmids. Expression of IkBaM in the RBL-2H3 cells resulted in the complete inhibition of NF-kB-dependent promoter activation in response to TNFa ( Figure 3A ). In contrast, IkBaM-expressing RBL-2H3 cells showed similar levels of Fc3RI-stimulated b-hexosaminidase release to the control cells (mock [36.2% ± 4.1%] versus IkBaM [34.7% ± 3.4%]; n = 5) ( Figure 3B ). Figure 3C shows that IkBaM is expressed in these cells. It thus appears that Fc3RI-induced degranulation is independent of NF-kB activation pathway. Since the IKK complex contains both IKK1/2 kinases, we next asked if mast cell degranulation requires both kinases. We generated FLMCs from IKK1
, IKK2 À/À , and IKK1/IKK2 À/À double knockout (Li et al., 2000) embryos and assayed for b-hexosaminidase activity following Fc3RI-induced degranulation. Figure 3D shows that release of b-hexosaminidase was impaired in both IKK2 À/À and IKK1
.7%]; n = 5; p < 0.01) ( Figure 3D ) to a much greater extent as compared with IKK1 À/À FLMCs (Figure 3D ). We thus conclude that IKK2 modulates IgE-induced degranulation by an NF-kB-independent mechanism.
IKK2 Is Recruited into the Lipid Raft Fractions upon Fc3RI Stimulation and Associates with SNAP-23
Mast cells contain the molecular machinery that drives membrane fusion during granule exocytosis. Essential to this process are soluble NSF (N-ehyl-maleimide-sensitive factor) attachment protein receptor (SNARE) proteins that lie on opposing cellular membranes to form a stable multimeric complex that catalyzes fusion (Jahn and Sudhof, 1999) . Mast cells express several plasma membrane-localized SNAREs (Q-SNAREs) that form part of the exocytotic machinery. Both SNAP-23 (Guo et al., 1998) and syntaxin 4 (Paumet et al., 2000) have been implicated in IgE-dependent fusion and are partly localized in lipid rafts, domains of the plasma membrane enriched in sphingolipids, and cholesterol (Puri and Roche, 2006; Kay et al., 2006; Chamberlain and Roche, 2001; Salaun et al., 2005) . Furthermore, it has been suggested that, in T cells, IKK1 and IKK2 are recruited to the lipid rafts at the immune synapse upon TCR activation (Thome and Tschopp, 2003; Thome, 2004) . Therefore, we first examined the recruitment of IKK2 into the lipid rafts after Fc3RI stimulation. Consistent with previous reports (Puri and Roche, 2006; Kay et al., 2006) , SNAP-23 and syntaxin 4 were detected in the membrane raft fractions before and after Fc3RI stimulation ( Figure 4A , cosedimentation with CTx in fraction 5). Little or no IKK2 was detected in the lipid raft fractions. In contrast, substantially increased levels of IKK2 were detected in the membrane raft fractions upon Fc3RI stimulation ( Figure 4A ), suggesting that IKK2 colocalizes with SNAP-23 and syntaxin 4 in the lipid rafts only after stimulation. We next examined whether IKK2 can associate with SNAP-23 or syntaxin 4 by coimunoprecipitation assay. GFP-tagged SNAP-23 was expressed with or without FLAG-tagged IKK2 in 293T cells and the amount of GFP-tagged SNAP-23 following imunoprecipitation with anti-FLAG mAb was evaluated. Anti-GFP mAb coprecipitated FLAG-tagged IKK2 ( Figure 4B ). In contrast, myc-tagged syntaxin 4 was not coprecipitated with FLAG-tagged IKK2 (data not shown). Furthermore, we examined whether IKK2 associates with SNAP-23 in the lipid raft fractions before and after Fc3RI stimulation. IKK2 and SNAP-23 coimmunoprecipitated in the raft fractions following Fc3RI stimulation ( Figure 4C ). These results suggest that IKK2 associates with SNAP-23 in the lipid rafts only after Fc3RI stimulation.
IKK2 Phosphorylates SNAP-23 on Ser120 and Ser95
Phosphorylation of SNAP-23 on Ser120 and Ser95 modulates regulated exocytosis in mast cells (Hepp et al., 2005) . We therefore examined whether SNAP-23 is a substrate for IKK2.
In vitro kinase assays showed that IKK2 phosphorylated , or IKK1 À/À FLMCs. IgE-induced b-hexosaminidase release was performed as described in Figure 2A . Data are means ± SD from five independent experiments; *p < 0.01. NS, not significant compared to WT.
SNAP-23 ( Figure 5A ). However, when Ser120, Ser95, or both were converted to Ala, phosphorylation of recombinant mutant SNAP-23 ( Figure 5B ) by IKK2 was substantially attenuated ( Figure 5A ), indicating that IKK2 can phosphorylate SNAP-23 at both Ser120 and Ser95 in vitro. To assess whether this phosphorylation by IKK2 occurs in vivo, we used phospho-specific antibodies (Hepp et al., 2005) . Consistent with previous report (Hepp et al., 2005) , Ser120 and Ser95 were phosophorylated upon Fc3RI stimulation in WT FLMCs ( Figure 5C ). In contrast, little or no phosphorylation was detected in IKK2 À/À FLMCs ( Figure 5C ). These results show that SNAP-23 is phosphorylated by IKK2 at Ser120 and Ser95 in vitro and in vivo, and that IKK2 is required for IgE-induced phosphorylation of SNAP-23. It has been reported that the complex of SNAP-23/syntaxin/VAMP is minimally required for membrane fusion (Weber et al., 1998) . Consistent with previous report (Puri and Roche, 2006) , syntaxin 4 and VAMP-2 coimmunoprecipitated with SNAP-23 in the lipid raft fractions after Fc3RI stimulation in WT, but not IKK2 À/À mast cells ( Figure 5D ). It thus appears that IKK2 regulates the formation of SNARE complex of SNAP-23/syntaxin 4/VAMP-2, resulting in the membrane fusions in the mast cells. We also examined whether VAMP-8 or VAMP-7 is a component of SNARE complex as v-SNAREs. VAMP-8, but not VAMP-7, was coimmunoprcipitated with SNAP-23 in the lipid raft fractions after Fc3RI stimulation in WT, but not IKK2
, mast cells ( Figure 5D ). This result suggests that, in addition to VAMP 2, VAMP-8 is also involved as v-SNAREs to mediate mast cell degranulation. shRNA, and FLAG-R-SNAP23 or FLAG-R-SNAP23AA, stably expressing RBL-2H3 cells were obtained as described in the Experimental Procedures. U6 or FLAG indicate control. IgE-induced b-hexosaminidase release was performed as described in Figure 2A . Data are means ± SD from five independent experiments *p < 0.01; NS, not significant. were infected with retroviruses of pMX-puro-FLAG-WT SANP-23, pMX-puro-FLAG-SNAP-23EE, or pMX-puro (mock). After selection with puromycin, IgEinduced b-hexosaminidase release was performed as described in Figure 2A . Data are means ± SD from five independent experiments; *p < 0.01; NS, not significant compared to mock-infected IKK2 À/À FLMCs. We designed (1) shRNA-resistant SNAP23 (R-SNAP23), which has three nucleotide mutations in siRNA target sequence; and (2) SNAP-23 shRNA-resistant SNAP23AA by mutating Ser95 and Ser120 in shRNA-resistant SNAP23 ( Figure S4A ). Downregulation of Fc3RI-stimulated b-hexosaminidase release by depletion of SNAP-23 (U6 + FLAG [41.6% ± 3.4%] versus shSNAP23 + FLAG [28.3% ± 3.0%]; n = 5; p < 0.01) ( Figure 6D ) was reversed in shRNA-resistant SNAP-23 (shSNAP23 + FLAG [28.3% ± 3.0%] versus shSNAP23 + FLAG-R-SNAP23 [45.6% ± 2.2%]; n = 5; p < 0.01) ( Figure 6D ), but not SNAP-23 shRNA-resistant SNAP23AA-expressing cells (shSNAP23 + FLAG [28.3% ± 3.0%] versus shSNAP23 + FLAG-R-SNAP23AA [31.2% ± 4.5%]; n = 5) ( Figure 6D ). We further investigated the effect of SNAP-23AA on IKK2-induced enhancement of Fc3RI-stimulated b-hexosaminidase. IKK2-induced enhancement of Fc3RI-stimulated b-hexosaminidase was observed in only SNAP-23 shRNAresitant SNAP23 ( Figure 6E ; shSNAP23 + GFP + FLAG-R-SNAP23 [43.7% ± 2.3%] versus shSNAP23 + GFP-IKK2 + FLAG-R-SNAP23 [59.2% ± 7.0%]; n = 5; p < 0.01), but not SNAP-23 shRNA-resitant SNAP23AA-expressing cells ( Figure S4C ) (shSNAP23 + GFP + FLAG-R-SNAP23AA [27.2% ± 4.0%] versus shSNAP23 + GFP-IKK2 + FLAG-R-SNAP23AA [30.9% ± 2.1%]; n = 5; p < 0.01) ( Figure 6E ). These results suggest that phosphorylation of SNAP-23 on Ser120 and Ser95 is required for IKK2-induced upregulation of Fc3RI-stimulated degranulation. To examine the effect of expression of phosphomimetic mutant of SNAP-23 in IKK2
À/À mast cells on Fc3RI-stimulated b-hexosaminidase release and in vivo early-phase passive cutaneous anaphylaxis (PCA) reactions, we generated phosphomimetic mutant SNAP23EE by mutating Ser95 and Ser120. IKK2 À/À FLMCs were infected with retroviruses of pMX-puro-FLAG-WT SNAP-23, pMX-puro-FALG-SNAP23EE, or pMX-puro (mock), and. as control, WT FLMCs were infected with mock vectors. All of these cells were selected with puromycin ( Figure S5 ) ± 8.8 pg/ml]; n = 5; p < 0.01), and A23187-induced TNF-a secretion ( Figure 7C : WT [273.8 ± 8.7 pg/ml] versus IKK2 À/À [50.8 ± 7.5 pg/ml]; n = 5; p < 0.01). It has been reported that NF-kB activation is critical for Fc3RI-induced TNF-a secretion (Klemm et al., 2006) . Therefore, we next examined the effect of overexpression of IKK2 or IkBaM in the mast cells on Fc3RI-stimulated TNF-a secretion. RBL-2H3 stably expressing GFP-IKK2 resulted in the increase of Fc3RI-stimulated TNF-a release (mock [50.8 ± 7.6 pg/ml] versus GFP-IKK2 [70.9 ± 5.0 pg/ml]; n = 5; p < 0.01) ( Figure 7D ). On the other hand, RBL-2H3 stably expressing GFP-IkBaM resulted in the diminished secretion of TNF-a upon thickness with a caliper before (baseline) and 1 hr after challenge. Data are means ± SD from six independent experiments; *p < 0.01; NS, not significant compared to mock-infected IKK2 À/À FLMC-reconstituted mice.
Fc3RI stimulation (mock [50.8 ± 7.6 pg/ml] versus GFP-IkBaM [16.4 ± 3.7 pg/ml]; n = 5; p < 0.01) ( Figure 7D ). These results indicate that IKK2-NF-kB signaling pathway plays critical roles in Fc3RI-induced TNF-a secretion from mast cells, resulting in late-phase allergic reactions. It is well known that the exocytotic process is also important to TNF-a secretion. Therefore, our results suggest that IKK2 can influence both SNAP23-(exocytosis) and NF-kB-dependent (transcription of TNF-a mRNA) pathways to regulate TNF-a release, respectively, during mast cell activation induced by Fc3RI aggregation.
DISCUSSION
We have shown that IKK2 promotes IgE-induced degranulation from mast cells by phosphorylating SNAP-23. First, we found that IKK2 plays a critical role in the induction of anaphylaxis in vivo (Figure 1 ). Second, we observed that IKK2 also plays a central regulatory role in IgE-induced degranulation by an NF-kB-independent mechanism (Figures 2 and 3) . Third, we found that IKK2 is recruited into lipid raft fractions upon Fc3RI stimulation ( Figure 4A ) and phosphorylates SNAP-23 at Ser120 and Ser95 ( Figures 5A and 5C ). Finally, depletion of SNAP-23 expression by RNAi (shRNA) prevented IKK2-mediated upregulation of IgE-induced degranulation, and expression of the phosphorylation mutant of SNAP-23 (SNAP-23SSAA) also prevented IKK2-mediated upregulation of IgE-induced degranulation (Figure 6 ). These results indicate that IKK2-induced SNAP-23 phosphorylation is a key event in SNARE complex formation, leading to IgE-induced degranulation in mast cells. Phosphorylation of IkB proteins by IKK complex, containing the catalytic kinases IKK1 and IKK2, and the regulatory, nonenzymatic scaffold proteins NEMO and ELKS, is an essential process to activate NF-kB proteins (NF-kB1, NF-kB2, RelA, c-Rel, and RelB). IKK2 is the major cytokine-responsive IkB kinase, while IKK1 is involved in noncanonical pathway (Hayden and Ghosh, 2004) , and may also function as a repressor of NF-kB signaling in some cells (Lawrence et al., 2005; Li et al., 2005; Correa et al., 2005) , We show that Fc3RI-stimulated b-hexosaminidase release is clearly impaired in IKK2 À/À FLMCs, but not in IKK1-deficient FLMCs. Consistent with our results, Peng et al. (2005) have demonstrated that inhibition of IKK2 by sulindac, which is a selective inhibitor of NEMO, resulted in the decrease of IgE-stimulated histamine release from mast cells. We were surprised to find that IkBaM, which is a superrepressor of NF-kB activation, does not have any significant effect on IgEinduced degranulation ( Figure 3B ), suggesting that IKK2 modulates IgE-induced degranulation by an NF-kB-independent mechanism. This is perhaps one of the very few cases where IKK2 functions in an NF-kB-independent manner, and opens the possibility that IKK2 may have additional substrates. We have shown that NF-kB activation is not essential for mast cell degranulation ( Figure 3B ). Klemm et al. (2006) have also shown the defect of NF-kB activation and normal degranulation in Bcl10 À/À or Malt1 À/À mast cells upon Fc3RI stimulation. Their results are consistent with ours, because only IKK complex, but not NF-kB, is activated in Bcl10 À/À T cells upon antigen receptor activation, suggesting that IKK2 can induce degranulation in the absence of NF-kB activation (Shambharkar et al., 2007) . The mechanism of antigen receptor-induced IKK complex activation is, however, still not fully understood, and requires further investigation.
Like TCR (Thome and Tschopp, 2003; Thome, 2004) or BCR (Thome, 2004) , IKK2 is recruited into lipid rafts upon Fc3RI stimulation ( Figure 4A ). However, antigen receptor-induced activation of IKK2 leads to NF-kB activity, resulting in the induction of the genes that regulate proliferation, cytokine production, and isotype switching (for B cells) (Li and Verma, 2002 ). In contrast, IKK2 associates with SNAP-23, highly enriched in lipid raft fractions only after Fc3RI stimulation ( Figure 4A ). More importantly, this association with SNAP-23 in lipid rafts leads to the phosphorylation of SNAP 23 at Ser95 and Ser120, essential for SNARE complex formation and degranulation (Figures 5B and 5C; Hepp et al., 2005) . There is increasing evidence that IKK2 regulates substrates other than IkBs, NF-kBs, or precursors, and mediate additional functions beyond NF-kB activation (Hu et al., 2004; Lee et al., 2004; Wegener et al., 2006) . Most of the NF-kB-related molecules (IkBa, IkBb, IkBg, NF-kB p105) have a putative IKK consensus sequences for phosphorylation (DSJXXS/T), and phosphorylation of these serine residues by IKK2 is required for subsequent ubiquitination and degradation (Karin and Ben-Neriah, 2000) . Like Bcl10 (Wegener et al., 2006) or 14-3-3b (Gringhuis et al., 2005) , SNAP-23 also contains no DSJXXS/T motif, which is the target for phosphorylation of IKK2 substrates. Phosphorylation of SNAP-23 promotes association with other SNARE proteins (Puri and Roche, 2006) to form the SNARE complex, rather than its degradation, more commonly observed with other IKK2 substrates. In light of these observations, we find it not surprising that phosphorylation sites of SNAP-23 by IKK2 are not identical for a putative IKK consensus sequences for phosphorylation (DSJXXS/T). We propose that SNAP-23 is highly enriched in lipid raft fractions before/after stimulation ( Figure 5D ). In contrast, only small amounts of syntaxin 4 or VAMP-2 are present in lipid raft fractions (Puri and Roche, 2006) (Figure 4A and Figure 5D, lanes 1 and 3) . Upon stimulation, IKK2 is recruited into the lipid raft fractions ( Figure 4A ), phosphorylates SNAP-23 at Ser 95 and Ser120, and now, essentially, most of syntaxin 4 and VAMP-2, the other two proteins in the SNARE complex, are in these raft fractions ( Figure 5D , lane 2). In IKK2 À/À cells either Syntaxin 4 or VAMP-2 can be found in the rafts ( Figure 5D , lane 4). SNAP-23 is anchored in the membrane by palmitioylation, and, following phosphorylation, recruits syntaxin 4 and VAMP-2 to form the SNARE complex. Thus phosphorylation of SNAP-23 by IKK2 is the key event in the formation and promotion of vesicle fusion with the plasma membrane, resulting in the degranulation in mast cells. Other groups have already shown that recombinant syntaxin 4/ SNAP-23 and VAMP-2 are capable of driving fusion in vitro (Vicogne et al., 2006; Shen et al., 2007) . However, these data do not rule out that SNAP-23 does not require phosphorylation for SNARE complex formation in vivo, because they demonstrated in vitro membrane fusion assay in which recombinant SNAREs were reconstituted on the artificial liposomes. We believe that this assay is suitable to show SNAREpin formation between some SNAREs, but it is inadequate to examine the molecular mechanism of translocation of SNAREs into lipid rafts, because, in many cases, artificial liposome is made without any cholesterol. Our result ( Figure 5D ) suggests that phosphorylation of SNAP-23 by IKK2 is an essential event in the colocalization of syntaxin 4 and VAMP-2 with SNAP-23 in lipid raft fractions during the exocytotic process. Our data highlight the importance of IKK2 in anaphylactic reactions, but does not rule out other mechanisms.
We have shown the essential role of IKK2 in mast cell degranulation (Figure 2 ) and early-phase allergic reactions (anaphylactic reactions) (Figure 3) . We have also shown that this regulation by IKK2 is dependent on SNAP-23 (Figure 6 ), but not NF-kB (Figure 3) . On the other hand, we have shown the important role of IKK2 in TNF-a release from mast cells and late-phase allergic reactions (Figure 7 ). Additionally, we have shown that regulation of TNF-a secretion by IKK2 is partially dependent on NF-kB activation, consistent with a previous report (Klemm et al., 2006) . Taken together, IKK2 in mast cells regulates early-phase allergic reactions in a SNAP-23-dependent manner, and, in late-phase allergic reactions, requires both SNAP-23 and NF-kB. Therefore, IKK2 is a central modulator in allergic reactions.
EXPERIMENTAL PROCEDURES
Mice IKK1- (Li et al., 1999b) and IKK2 (Li et al., 1999a ) -heterozygous mice were backcrossed for over eight generations onto C57BL/6 mice. Genetically mast cell-deficient mice, WBB6F1-W/W v mice (W/W v mice) were purchased from The Jackson Laboratory. Mice were bred and housed in the animal care facility at the Salk Institute. Experimental procedures involving mice followed the guidelines from the National Institutes of Health, and were approved by the Animal Use Committee at the Salk Institute. PCA and PSA To elicit PCA, 4 weeks after FLMC transplantation, mice were first primed with IgE by intradermal injection in the ears, with 100 ng monoclonal mouse dinitrophenol-specific (anti-DNP) IgE (Sigma) in 20 ml of PBS. After 24 hr, mice were injected i.v. with 200 mg of DNP-HSA (human serum albumin; Sigma) diluted in sterile 0.9% NaCl. Ear swelling was quantified by three consecutive measurements of ear thickness with a caliper before (baseline) and 1, 2, 3, and 4 hr after antigen challenge. In some experiments, 0.5% Evans blue dye was injected with DNP-HSA. To elicit PSA, 4 weeks later, FLMCs transplantation, mice were first primed with IgE by i.v. injection, with 20 mg anti-DNP IgE in 100 ml of PBS. After 24 hr, mice were injected i.v. with 1 mg of DNP-HSA diluted in sterile 0.9% NaCl. The systemic anaphylactic response was monitored by measuring rectal temperature several times after antigen challenge.
Cell Culture
Late-Phase Allergic Reactions
To elicit late-phase PCA reactions, 4 weeks after FLMC transplantation, mice were first primed with IgE by i.v. injection with 20 mg anti-DNP IgE in 100 ml of PBS. After 24 hr, mice were challenged by epicutaneous application of 10 ml of DNFB (0.2% w/v) in acetone:olive oil (4:1) to both sides of both ears. The ear swelling response was assessed by measuring the ear thickness with caliper before (baseline) and 2, 4, 6, 8, 12, 24 , and 48 hr after hapten challenge. The increment of ear thickness (postchallenge value À prechallenge baseline value) was expressed as the percent of the baseline value.
Data Analysis
Data are summarized as mean ± SD. The statistical analysis of the results was performed by the unpaired t test; p values < 0.05 were considered significant.
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